No Data
Guoke Hengtai: Report for the third quarter of 2024
Express News | Guoke Hengtai: Shareholder Junlian Yikang plans to reduce its shareholding by no more than 3% of the company's shares.
Guoke Hengtai (301370.SZ): High-value consumables such as interventional cardiology, orthopedics, neurosurgery, and rehabilitation are suitable for the elderly patient group.
Gelonghui | September 26 | Guokelongtai (301370.SZ) stated at an investor relations event that aging and urbanization will jointly drive the continuous growth of China's demand for medical instruments. As the population peak born in the mid-20th century gradually enters old age, the early 21st century will be the period with the fastest aging population development in China. In 2023, the elderly population aged 65 and above in China is 217 million people, accounting for 15.4% of the total population, with an additional 7.91 million elderly people compared to the birth population. (Data Source: National Bureau of Statistics) According to the United Nations Population Fund forecast, by 2030, China's population aged 65 and above
Guoke Hengtai (301370.SZ) plans to increase its capital to Guizhou Guoke subsidiary by 9.9 million yuan.
Guoke Hengtai (301370.SZ) has issued an announcement to meet the needs of its wholly-owned subsidiary, Guizhou Guoke Hengtai Medical Technology Co., Ltd...
Express News | Guoke Hengtai: Waive the priority right to purchase equity transfer of a subsidiary's controlling stake.
Guoke Hengtai: 2024 Semi-Annual Report
No Data
No Data